Tumor-Associated Raynaud's Phenomenon Exacerbated by Administration of Immune Checkpoint Inhibitors

J Thorac Oncol. 2022 Oct;17(10):1233-1234. doi: 10.1016/j.jtho.2022.07.004.

¹ Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan. Electronic address: tsh715@gmail.com.
² Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.
³ Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan.
⁴ Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.

No abstract available

Keywords: Immune checkpoint inhibitors; Lung cancer; Raynaud's phenomenon; Squamous cell carcinoma.

MeSH terms